Suven Life Sciences Balance Sheet Health
Financial Health criteria checks 5/6
Suven Life Sciences has a total shareholder equity of ₹1.9B and total debt of ₹0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₹2.1B and ₹192.8M respectively.
Key information
0%
Debt to equity ratio
₹0
Debt
| Interest coverage ratio | n/a |
| Cash | ₹1.66b |
| Equity | ₹1.93b |
| Total liabilities | ₹192.80m |
| Total assets | ₹2.12b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 530239's short term assets (₹1.9B) exceed its short term liabilities (₹179.3M).
Long Term Liabilities: 530239's short term assets (₹1.9B) exceed its long term liabilities (₹13.5M).
Debt to Equity History and Analysis
Debt Level: 530239 is debt free.
Reducing Debt: 530239 has no debt compared to 5 years ago when its debt to equity ratio was 13.2%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 530239 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 530239 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 8.5% each year